New drug duo aims to stop lung cancer in its tracks
Disease control
Ongoing
This study tests whether two immunotherapy drugs, balstilimab and botensilimab, can safely control advanced non-small cell lung cancer. About 45 people who have not had prior treatment for metastatic disease will receive the combination. The main goal is to see how many patients …
Phase: PHASE2 • Sponsor: Immune Oncology Research Institute • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC